Digital health tools are transforming cancer prevention with personalized risk assessments, AI-driven insights, and remote care delivery. Mobile apps, wearables, and telehealth platforms enhance engagement, monitoring…
This compilation of research underscores the pivotal role of policy interventions in global cancer prevention efforts. It examines how policies influence lifestyle choices, environmental factors, and healthcare access…
This compilation of research underscores the critical need for equitable access to cancer prevention services. It examines various barriers including socioeconomic, geographic, cultural, and financial factors, as well…
Cancer prevention research is shifting towards personalized strategies using multi-omics data and AI for early detection and risk assessment. Investigations into the tumor microenvironment, epigenetics, microbiome, and…
Prognostic markers are crucial for predicting patient outcomes and guiding treatment in ovarian cancer. Current research focuses on a wide array of biomarkers including traditional ones like CA-125, alongside…
This review synthesizes current trends and future directions in gynecologic cancer screening, emphasizing early detection for improved patient outcomes. It covers advancements in cervical, ovarian, and endometrial…
PI3K pathway is a critical signaling cascade frequently dysregulated in ovarian cancer, driving proliferation, survival, and resistance to therapy. Targeting this pathway offers a promising therapeutic strategy, with…
Angiogenesis is crucial for gynecologic cancer growth and metastasis. Targeting this process offers therapeutic potential. VEGF is a key driver, with anti-VEGF therapies showing clinical benefit. Resistance mechanisms…
Lymphatic invasion is a key prognostic factor in endometrial cancer, impacting treatment and outcomes due to its association with lymph node metastasis. Accurate identification through histopathology and advanced imaging
MicroRNAs (miRNAs) are pivotal in endometrial cancer (EC) development, impacting key cellular processes and disease progression. This review synthesizes current understanding of miRNA roles, including their functions as…
Chemoresistance significantly impacts ovarian cancer treatment outcomes, often leading to relapse. This review consolidates insights into the multifaceted mechanisms driving this resistance. Key contributors include…
Cervical cancer prevention relies heavily on strategies targeting the human papillomavirus (HPV). Key interventions include HPV vaccination to reduce infection incidence and cervical cancer screening for early detection…
This review synthesizes current knowledge on cervical cancer metastasis, detailing its intricate mechanisms from primary tumor to distant sites. It highlights the roles of epithelial-mesenchymal transition (EMT), the…
Recent advancements in radiotherapy for ovarian cancer are enhancing treatment outcomes through precise imaging, advanced techniques like IMRT and adaptive radiotherapy, and combination therapies. Innovations aim to…
Colorectal cancer (CRC) remains one of the most prevalent malignancies worldwide, representing a major contributor to cancer-related morbidity and mortality. Despite advances in screening, diagnostics, and therapeutic…
Lung cancer remains one of the most lethal malignancies worldwide, largely due to late-stage diagnosis and limited efficacy of traditional therapies such as chemotherapy and radiation. Over the past ... tumor cells…
Quality of life (QoL) in cancer patients has emerged as a central outcome in modern oncology, complementing traditional survival-based endpoints. Advances in early detection and therapeutic strategies have increased…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.